SEC Form 4Coverage since May 27, 2026
$EW insider trading
Over the last 12 months, Edwards Lifesciences insiders reported no purchases and 8 sales totaling $3.3M across SEC Form 4 filings. 38% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $3.3M 8 events
- Events · 12m
- 8 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 38% pre-arranged plans
Side
Price · $EW · 12Mvia TradingView
Top insiders · 12m
Lippis Daniel J.CVP, TAVR2× · $113K
Zovighian Bernard JCEO2× · $291K
Markowitz WayneCVP, JAPAC2× · $832K
Dahl Andrew M.SVP, Corporate Controller1× · $49K
BOBO DONALD E JRCVP,Strategy/Corp Development1× · $2.0M
All insider trades
8 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Markowitz WayneCVP, JAPAC · O | ▼ Sale | 146.313 | $86.03 | $13K | -0.7% | — |
| Jul 28, 2026 | Markowitz WayneCVP, JAPAC · O | ▼ Sale | 9,628 | $85.06 | $819K | -30.8% | — |
| Jul 27, 2026 | Zovighian Bernard JCEO · O·D | ▼ Sale | 2,920.551 | $83.93 | $245K | -24.7% | indirect |
| Jul 10, 2026 | Lippis Daniel J.CVP, TAVR · O | ▼ Sale | 619 | $91.7 | $57K | -1.5% | plan |
| Jun 30, 2026 | Lippis Daniel J.CVP, TAVR · O | ▼ Sale | 619 | $91.4 | $57K | -1.5% | plan |
| Jun 17, 2026 | Zovighian Bernard JCEO · O·D | ▼ Sale | 523 | $87.92 | $46K | -4.3% | plan · indirect |
| May 29, 2026 | Dahl Andrew M.SVP, Corporate Controller · O | ▼ Sale | 567.527 | $86.08 | $49K | -3.6% | — |
| May 27, 2026 | BOBO DONALD E JRCVP,Strategy/Corp Development · O | ▼ Sale | 23,145 | $86.42 | $2.0M | -19% | indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $EW feed.